Pivotal Bioscience

LP_

About

Pivotal Bioscience ('PB') is a distributor of Active Pharmaceutical, Nutraceutical and Cosmetic Ingredients, predominantly to the Compounding Pharmacy sector.

Additionally, PB is a manufacturer of beta Nicotinamide Mononucleotide ('NMN') produced using Enzyme Catalysis/'Biocatalysis' technology (also referred to as "Green Chemistry") in the European Union, in a cGMP ISO 9001 certified Pharmaceutical CMO facility.

Biocatalysis technology derives a final finished ingredient material devoid of residual Organic Solvents ('OS') content [unlike conventional synthetic chemical synthesis ('SCS')], with an ultra-low Endotoxin content.

The majority of OS used in SCS are toxic/carcinogenic, and ingredient materials derived therefrom inherently contain a residual OS content to some degree, the magnitude of which is determined by manufacturing QC/QA policies and processes during manufacture.

NMN produced by SCS is no exception, hence Biocatalysis is our chosen manufacturing technology.

Absence of residual OS content in conjunction with ultra-low Endotoxin content, together confer suitability of our NMN as a parenteral intermediate ingredient material for further processing to Compounding Pharmacy formulated and dispensed preparations.

As well as being a direct manufacturing supply resource of NMN bulk ingredient material to consumer/retail finished product formulators and manufacturers, PB also custom formulates, designs and facilitates manufacturing of White-label turn-key finished product solutions (Oral - ingested and sublingual, Nasal and Parenteral) on behalf of qualifying customers.

Turn-key finished products are packaged in qualifying FDA^(US)/Health Canada/BRC^(UK)/TGA^(AU) registered, cGMP certified, state-of-the-art contract manufacturing facilities in the USA, Canada, UK and Australia.

RP_